THINK Surgical, Inc. has announced that its TMINI Miniature Robotic System received FDA 510(k) clearance for use with the LinkSymphoKnee (LSK) implants from Waldemar Link GmbH & Co. KG (LINK). This clearance expands the utility of the TMINI system in primary knee replacement surgeries, offering surgeons a precise and adaptable tool.
The LinkSymphoKnee implant has been integrated into THINK Surgical’s ID-HUB, a database of implant modules compatible with the open platform version of the TMINI System in the United States. This integration provides surgeons with a cost-effective, hand-held robotic option that complements the LinkSymphoKnee primary products.
"Through this partnership, we’re not only providing a state-of-the-art robotic solution but a nimble, cost-effective, hand-held option that complements the full spectrum of our LinkSymphoKnee primary products," said Greg Pomasl, president of LINK in the USA (LinkBio Corporation).
Stuart Simpson, president and CEO of THINK Surgical, stated, "THINK Surgical is excited to add the LinkSymphoKnee to the TMINI System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic, and guided motion knees on a single robotic platform."
The TMINI system aims to enhance surgical precision and improve patient outcomes in knee replacement procedures. The collaboration between THINK Surgical and Waldemar Link GmbH & Co. KG seeks to provide surgeons with advanced tools for delivering exceptional patient care.
